|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
royalwulff55
|
1.7K |
919K |
30 |
05/12/25 |
| 05/12/25 |
ASX - By Stock
|
1.7K
|
919K
|
30
|
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
royalwulff55
|
1.7K |
919K |
30 |
05/12/25 |
| 05/12/25 |
ASX - By Stock
|
1.7K
|
919K
|
30
|
|
|
ASX - By Stock
|
NEU |
Re:
Rest of world sales
|
|
royalwulff55
|
16 |
6.1K |
101 |
02/12/25 |
| 02/12/25 |
ASX - By Stock
|
16
|
6.1K
|
101
|
|
|
ASX - By Stock
|
NEU |
Re:
Rest of world sales
|
|
royalwulff55
|
16 |
6.1K |
19 |
02/12/25 |
| 02/12/25 |
ASX - By Stock
|
16
|
6.1K
|
19
|
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
royalwulff55
|
17K |
8.7M |
28 |
12/11/25 |
| 12/11/25 |
ASX - By Stock
|
17K
|
8.7M
|
28
|
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
royalwulff55
|
1.7K |
919K |
41 |
12/11/25 |
| 12/11/25 |
ASX - By Stock
|
1.7K
|
919K
|
41
|
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
royalwulff55
|
17K |
8.7M |
8 |
07/11/25 |
| 07/11/25 |
ASX - By Stock
|
17K
|
8.7M
|
8
|
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
royalwulff55
|
1.7K |
919K |
5 |
06/11/25 |
| 06/11/25 |
ASX - By Stock
|
1.7K
|
919K
|
5
|
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
royalwulff55
|
2.0K |
1.1M |
16 |
31/10/25 |
| 31/10/25 |
ASX - By Stock
|
2.0K
|
1.1M
|
16
|
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
royalwulff55
|
2.0K |
1.1M |
58 |
31/10/25 |
| 31/10/25 |
ASX - By Stock
|
2.0K
|
1.1M
|
58
|
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Fast Track granted by FDA for NNZ-2591 in Phelan-McDermid
|
|
royalwulff55
|
54 |
22K |
16 |
29/10/25 |
| 29/10/25 |
ASX - By Stock
|
54
|
22K
|
16
|
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
royalwulff55
|
1.7K |
919K |
4 |
28/10/25 |
| 28/10/25 |
ASX - By Stock
|
1.7K
|
919K
|
4
|
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
royalwulff55
|
1.7K |
919K |
10 |
28/10/25 |
| 28/10/25 |
ASX - By Stock
|
1.7K
|
919K
|
10
|
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
royalwulff55
|
1.7K |
919K |
38 |
27/10/25 |
| 27/10/25 |
ASX - By Stock
|
1.7K
|
919K
|
38
|
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
royalwulff55
|
17K |
8.7M |
26 |
20/10/25 |
| 20/10/25 |
ASX - By Stock
|
17K
|
8.7M
|
26
|
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Application for quotation of securities - NEU
|
|
royalwulff55
|
9 |
4.9K |
3 |
04/10/25 |
| 04/10/25 |
ASX - By Stock
|
9
|
4.9K
|
3
|
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Application for quotation of securities - NEU
|
|
royalwulff55
|
9 |
4.9K |
1 |
04/10/25 |
| 04/10/25 |
ASX - By Stock
|
9
|
4.9K
|
1
|
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Application for quotation of securities - NEU
|
|
royalwulff55
|
9 |
4.9K |
6 |
04/10/25 |
| 04/10/25 |
ASX - By Stock
|
9
|
4.9K
|
6
|
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
royalwulff55
|
17K |
8.7M |
24 |
03/10/25 |
| 03/10/25 |
ASX - By Stock
|
17K
|
8.7M
|
24
|
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
royalwulff55
|
17K |
8.7M |
30 |
09/09/25 |
| 09/09/25 |
ASX - By Stock
|
17K
|
8.7M
|
30
|
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
royalwulff55
|
17K |
8.7M |
9 |
09/09/25 |
| 09/09/25 |
ASX - By Stock
|
17K
|
8.7M
|
9
|
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
royalwulff55
|
17K |
8.7M |
33 |
09/09/25 |
| 09/09/25 |
ASX - By Stock
|
17K
|
8.7M
|
33
|
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
royalwulff55
|
17K |
8.7M |
127 |
09/09/25 |
| 09/09/25 |
ASX - By Stock
|
17K
|
8.7M
|
127
|
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
royalwulff55
|
17K |
8.7M |
17 |
05/09/25 |
| 05/09/25 |
ASX - By Stock
|
17K
|
8.7M
|
17
|
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
royalwulff55
|
2.0K |
1.1M |
4 |
01/09/25 |
| 01/09/25 |
ASX - By Stock
|
2.0K
|
1.1M
|
4
|
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
royalwulff55
|
2.0K |
1.1M |
36 |
01/09/25 |
| 01/09/25 |
ASX - By Stock
|
2.0K
|
1.1M
|
36
|
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
royalwulff55
|
17K |
8.7M |
35 |
12/08/25 |
| 12/08/25 |
ASX - By Stock
|
17K
|
8.7M
|
35
|
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren adds SYNGAP1-related disorder to NNZ-2591 pipeline
|
|
royalwulff55
|
78 |
38K |
38 |
08/08/25 |
| 08/08/25 |
ASX - By Stock
|
78
|
38K
|
38
|
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren adds SYNGAP1-related disorder to NNZ-2591 pipeline
|
|
royalwulff55
|
78 |
38K |
15 |
08/08/25 |
| 08/08/25 |
ASX - By Stock
|
78
|
38K
|
15
|
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
royalwulff55
|
17K |
8.7M |
14 |
25/07/25 |
| 25/07/25 |
ASX - By Stock
|
17K
|
8.7M
|
14
|
|
|
Charts
|
NEU |
Re:
NEU chart
|
|
royalwulff55
|
2.4K |
1.4M |
8 |
24/07/25 |
| 24/07/25 |
Charts
|
2.4K
|
1.4M
|
8
|
|
|
Charts
|
NEU |
Re:
NEU chart
|
|
royalwulff55
|
2.4K |
1.4M |
8 |
24/07/25 |
| 24/07/25 |
Charts
|
2.4K
|
1.4M
|
8
|
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
royalwulff55
|
1.7K |
919K |
21 |
24/07/25 |
| 24/07/25 |
ASX - By Stock
|
1.7K
|
919K
|
21
|
|
|
Charts
|
NEU |
Re:
NEU chart
|
|
royalwulff55
|
2.4K |
1.4M |
2 |
23/07/25 |
| 23/07/25 |
Charts
|
2.4K
|
1.4M
|
2
|
|
|
Charts
|
NEU |
Re:
NEU chart
|
|
royalwulff55
|
2.4K |
1.4M |
8 |
22/07/25 |
| 22/07/25 |
Charts
|
2.4K
|
1.4M
|
8
|
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Change of Director's Interest Notice - J Pilcher
|
|
royalwulff55
|
24 |
13K |
18 |
22/07/25 |
| 22/07/25 |
ASX - By Stock
|
24
|
13K
|
18
|
|
|
ASX - By Stock
|
NEU |
Re:
Dividend reinvestment plan for Neu
|
|
royalwulff55
|
35 |
15K |
21 |
22/07/25 |
| 22/07/25 |
ASX - By Stock
|
35
|
15K
|
21
|
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
royalwulff55
|
17K |
8.7M |
2 |
16/07/25 |
| 16/07/25 |
ASX - By Stock
|
17K
|
8.7M
|
2
|
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
royalwulff55
|
17K |
8.7M |
35 |
15/07/25 |
| 15/07/25 |
ASX - By Stock
|
17K
|
8.7M
|
35
|
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
royalwulff55
|
17K |
8.7M |
36 |
14/07/25 |
| 14/07/25 |
ASX - By Stock
|
17K
|
8.7M
|
36
|
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
royalwulff55
|
1.7K |
919K |
51 |
03/07/25 |
| 03/07/25 |
ASX - By Stock
|
1.7K
|
919K
|
51
|
|
|
ASX - By Stock
|
NEU |
Re:
M&A
|
|
royalwulff55
|
311 |
174K |
31 |
30/05/25 |
| 30/05/25 |
ASX - By Stock
|
311
|
174K
|
31
|
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Update - Notification of buy-back - NEU
|
|
royalwulff55
|
27 |
11K |
36 |
09/05/25 |
| 09/05/25 |
ASX - By Stock
|
27
|
11K
|
36
|
|
|
ASX - By Stock
|
NEU |
Re:
Ann: DAYBUE Q1 2025 net sales US$84.6m up 11% from Q1 2024
|
|
royalwulff55
|
48 |
25K |
15 |
08/05/25 |
| 08/05/25 |
ASX - By Stock
|
48
|
25K
|
15
|
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
royalwulff55
|
17K |
8.7M |
13 |
02/05/25 |
| 02/05/25 |
ASX - By Stock
|
17K
|
8.7M
|
13
|
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren appoints Daryl DeKarske to executive team
|
|
royalwulff55
|
20 |
12K |
34 |
02/05/25 |
| 02/05/25 |
ASX - By Stock
|
20
|
12K
|
34
|
|
|
ASX - By Stock
|
NEU |
Re:
Ann: NEU confirms primary endpoints for Phase 3 trial in PMS
|
|
royalwulff55
|
160 |
85K |
31 |
15/04/25 |
| 15/04/25 |
ASX - By Stock
|
160
|
85K
|
31
|
|
|
ASX - By Stock
|
NEU |
Re:
Ann: NEU confirms primary endpoints for Phase 3 trial in PMS
|
|
royalwulff55
|
160 |
85K |
1 |
14/04/25 |
| 14/04/25 |
ASX - By Stock
|
160
|
85K
|
1
|
|
|
ASX - By Stock
|
NEU |
Re:
Ann: NEU confirms primary endpoints for Phase 3 trial in PMS
|
|
royalwulff55
|
160 |
85K |
10 |
14/04/25 |
| 14/04/25 |
ASX - By Stock
|
160
|
85K
|
10
|
|
|
ASX - By Stock
|
NEU |
Re:
Ann: NEU confirms primary endpoints for Phase 3 trial in PMS
|
|
royalwulff55
|
160 |
85K |
24 |
14/04/25 |
| 14/04/25 |
ASX - By Stock
|
160
|
85K
|
24
|
|